FTC Wants Access To Boehringer Docs In Pay-For-Delay Probe

Law360, New York (September 12, 2013, 9:24 PM EDT) -- The Federal Trade Commission told the D.C. Circuit on Wednesday that it should force Boehringer Ingelheim Pharmaceuticals Inc. to turn over documents about a $100 million drug co-promotion deal with Barr Pharmaceuticals Inc., saying the information could indicate an unlawful pay-for-delay agreement.

The documents cover financial analyses of both the co-promotion deal and an agreement from Barr to drop patents challenges to two of Boehringer’s branded drugs. They are crucial to the FTC's investigation into whether Boehringer used the agreements to compensate Barr for delaying competitive...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

FTC v. Boehringer Ingelheim Pharmace


Case Number

12-5393

Court

Appellate - DC Circuit

Nature of Suit

2890 Other Statutory Actions

Date Filed

December 12, 2012

Law Firms

Companies

Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.